MindwaysCT receives FDA clearance for bone mineral density measurement technology

 
MindwaysCT received 510(k) clearance from the U.S. Food and Drug Administration to market its quantitative computed tomography calibration technology for CT-based bone mineral density measurement.

Advertisement

MindwaysCT’s latest QCT software innovation makes it possible to assess bone mineral density using QCT without the need to scan a calibration phantom together with the patient. The new technology can also offer retrospective analysis of previously acquired images.

More articles on devices:

aap Implantate receives patent for LOQTEQ
NuVasive COO sells 2.5k shares in $87k transaction
$0.9B by 2019: 3D printing in medical applications market analysis

 

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.